Clinical Trial
Published on 09 Oct 2025
Targeting cardiovascular and metabolic risk modification in end stage renal disease (ESRD): a randomized controlled clinical trial on niacin’s effects on lipoprotein(a) and biochemical markers in hemodialysis patients
in Nephrology
- 513 views